Anthera Pharmaceuticals to price public offering of common shares

Bookrunner Jefferies and co-manager Leerink Swann assist

By Devika Patel

Knoxville, Tenn., Jan. 24 - Anthera Pharmaceuticals, Inc. plans to price a public offering of common stock with a 30-day greenshoe option, according to a prospectus supplement filed Thursday with the Securities and Exchange Commission.

Jefferies is the bookrunning manager, and Leerink Swann is the co-manager.

Proceeds will be used for general corporate purposes.

Anthera, based in Hayward, Calif., is a biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.